Cargando…
MRI-Determined Psoas Muscle Fat Infiltration Correlates with Severity of Weight Loss during Cancer Cachexia
SIMPLE SUMMARY: During cancer cachexia, patients experience profound weight loss due to metabolic dysfunction, resulting in muscle composition alterations. The proton density fat fraction (PDFF) using magnetic resonance imaging (MRI) is an established biomarker to assess changes of muscle compositio...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431175/ https://www.ncbi.nlm.nih.gov/pubmed/34503243 http://dx.doi.org/10.3390/cancers13174433 |
_version_ | 1783750875335884800 |
---|---|
author | Patzelt, Lisa Junker, Daniela Syväri, Jan Burian, Egon Wu, Mingming Prokopchuk, Olga Nitsche, Ulrich Makowski, Marcus R. Braren, Rickmer F. Herzig, Stephan Diaz, Mauricio Berriel Karampinos, Dimitrios C. |
author_facet | Patzelt, Lisa Junker, Daniela Syväri, Jan Burian, Egon Wu, Mingming Prokopchuk, Olga Nitsche, Ulrich Makowski, Marcus R. Braren, Rickmer F. Herzig, Stephan Diaz, Mauricio Berriel Karampinos, Dimitrios C. |
author_sort | Patzelt, Lisa |
collection | PubMed |
description | SIMPLE SUMMARY: During cancer cachexia, patients experience profound weight loss due to metabolic dysfunction, resulting in muscle composition alterations. The proton density fat fraction (PDFF) using magnetic resonance imaging (MRI) is an established biomarker to assess changes of muscle composition. We evaluated the suitability of MRI-determined psoas and erector spinae muscle PDFF and fat volume as biomarkers for monitoring cachexia development in an oncological cohort of 58 patients and assessed the regional variation in muscle parameters over time. Our results indicate that psoas muscle PDFF and fat volume could serve as MRI-determined biomarkers for early risk stratification and disease monitoring regarding progression and severity of weight loss in cancer cachexia. ABSTRACT: Purpose: To evaluate the suitability of psoas and erector spinae muscle proton density fat fraction (PDFF) and fat volume as biomarkers for monitoring cachexia severity in an oncological cohort, and to evaluate regional variances in muscle parameters over time. Methods: In this prospective study, 58 oncological patients were examined by a 3 T MRI receiving between one and five scans. Muscle volume and PDFF were measured, segmentation masks were divided into proximal, middle and distal muscle section. Results: A regional variation of fat distribution in erector spinae muscle at baseline was found (p < 0.01). During follow-ups significant relative change of muscle parameters was observed. Relative maximum change of erector spinae muscle showed a significant regional variation. Correlation testing with age as a covariate revealed significant correlations for baseline psoas fat volume (r = −0.55, p < 0.01) and baseline psoas PDFF (r = −0.52, p = 0.02) with maximum BMI change during the course of the disease. Conclusion: In erector spinae muscles, a regional variation of fat distribution at baseline and relative maximum change of muscle parameters was observed. Our results indicate that psoas muscle PDFF and fat volume could serve as MRI-determined biomarkers for early risk stratification and disease monitoring regarding progression and severity of weight loss in cancer cachexia. |
format | Online Article Text |
id | pubmed-8431175 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84311752021-09-11 MRI-Determined Psoas Muscle Fat Infiltration Correlates with Severity of Weight Loss during Cancer Cachexia Patzelt, Lisa Junker, Daniela Syväri, Jan Burian, Egon Wu, Mingming Prokopchuk, Olga Nitsche, Ulrich Makowski, Marcus R. Braren, Rickmer F. Herzig, Stephan Diaz, Mauricio Berriel Karampinos, Dimitrios C. Cancers (Basel) Article SIMPLE SUMMARY: During cancer cachexia, patients experience profound weight loss due to metabolic dysfunction, resulting in muscle composition alterations. The proton density fat fraction (PDFF) using magnetic resonance imaging (MRI) is an established biomarker to assess changes of muscle composition. We evaluated the suitability of MRI-determined psoas and erector spinae muscle PDFF and fat volume as biomarkers for monitoring cachexia development in an oncological cohort of 58 patients and assessed the regional variation in muscle parameters over time. Our results indicate that psoas muscle PDFF and fat volume could serve as MRI-determined biomarkers for early risk stratification and disease monitoring regarding progression and severity of weight loss in cancer cachexia. ABSTRACT: Purpose: To evaluate the suitability of psoas and erector spinae muscle proton density fat fraction (PDFF) and fat volume as biomarkers for monitoring cachexia severity in an oncological cohort, and to evaluate regional variances in muscle parameters over time. Methods: In this prospective study, 58 oncological patients were examined by a 3 T MRI receiving between one and five scans. Muscle volume and PDFF were measured, segmentation masks were divided into proximal, middle and distal muscle section. Results: A regional variation of fat distribution in erector spinae muscle at baseline was found (p < 0.01). During follow-ups significant relative change of muscle parameters was observed. Relative maximum change of erector spinae muscle showed a significant regional variation. Correlation testing with age as a covariate revealed significant correlations for baseline psoas fat volume (r = −0.55, p < 0.01) and baseline psoas PDFF (r = −0.52, p = 0.02) with maximum BMI change during the course of the disease. Conclusion: In erector spinae muscles, a regional variation of fat distribution at baseline and relative maximum change of muscle parameters was observed. Our results indicate that psoas muscle PDFF and fat volume could serve as MRI-determined biomarkers for early risk stratification and disease monitoring regarding progression and severity of weight loss in cancer cachexia. MDPI 2021-09-02 /pmc/articles/PMC8431175/ /pubmed/34503243 http://dx.doi.org/10.3390/cancers13174433 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Patzelt, Lisa Junker, Daniela Syväri, Jan Burian, Egon Wu, Mingming Prokopchuk, Olga Nitsche, Ulrich Makowski, Marcus R. Braren, Rickmer F. Herzig, Stephan Diaz, Mauricio Berriel Karampinos, Dimitrios C. MRI-Determined Psoas Muscle Fat Infiltration Correlates with Severity of Weight Loss during Cancer Cachexia |
title | MRI-Determined Psoas Muscle Fat Infiltration Correlates with Severity of Weight Loss during Cancer Cachexia |
title_full | MRI-Determined Psoas Muscle Fat Infiltration Correlates with Severity of Weight Loss during Cancer Cachexia |
title_fullStr | MRI-Determined Psoas Muscle Fat Infiltration Correlates with Severity of Weight Loss during Cancer Cachexia |
title_full_unstemmed | MRI-Determined Psoas Muscle Fat Infiltration Correlates with Severity of Weight Loss during Cancer Cachexia |
title_short | MRI-Determined Psoas Muscle Fat Infiltration Correlates with Severity of Weight Loss during Cancer Cachexia |
title_sort | mri-determined psoas muscle fat infiltration correlates with severity of weight loss during cancer cachexia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431175/ https://www.ncbi.nlm.nih.gov/pubmed/34503243 http://dx.doi.org/10.3390/cancers13174433 |
work_keys_str_mv | AT patzeltlisa mrideterminedpsoasmusclefatinfiltrationcorrelateswithseverityofweightlossduringcancercachexia AT junkerdaniela mrideterminedpsoasmusclefatinfiltrationcorrelateswithseverityofweightlossduringcancercachexia AT syvarijan mrideterminedpsoasmusclefatinfiltrationcorrelateswithseverityofweightlossduringcancercachexia AT burianegon mrideterminedpsoasmusclefatinfiltrationcorrelateswithseverityofweightlossduringcancercachexia AT wumingming mrideterminedpsoasmusclefatinfiltrationcorrelateswithseverityofweightlossduringcancercachexia AT prokopchukolga mrideterminedpsoasmusclefatinfiltrationcorrelateswithseverityofweightlossduringcancercachexia AT nitscheulrich mrideterminedpsoasmusclefatinfiltrationcorrelateswithseverityofweightlossduringcancercachexia AT makowskimarcusr mrideterminedpsoasmusclefatinfiltrationcorrelateswithseverityofweightlossduringcancercachexia AT brarenrickmerf mrideterminedpsoasmusclefatinfiltrationcorrelateswithseverityofweightlossduringcancercachexia AT herzigstephan mrideterminedpsoasmusclefatinfiltrationcorrelateswithseverityofweightlossduringcancercachexia AT diazmauricioberriel mrideterminedpsoasmusclefatinfiltrationcorrelateswithseverityofweightlossduringcancercachexia AT karampinosdimitriosc mrideterminedpsoasmusclefatinfiltrationcorrelateswithseverityofweightlossduringcancercachexia |